Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00MCJ
|
|||
Former ID |
DNC003612
|
|||
Drug Name |
6-(1H-Benzoimidazol-2-yl)-benzocyclohepten-7-one
|
|||
Synonyms |
benzoannulenone 1; AC1NS6NT; CHEMBL327029; BDBM5326; 6-(1H-benzimidazol-2-yl)benzo[7]annulen-7-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H12N2O
|
|||
Canonical SMILES |
C1=CC=C2C=C(C(=O)C=CC2=C1)C3=NC4=CC=CC=C4N3
|
|||
InChI |
1S/C18H12N2O/c21-17-10-9-12-5-1-2-6-13(12)11-14(17)18-19-15-7-3-4-8-16(15)20-18/h1-11H,(H,19,20)
|
|||
InChIKey |
OZPIXWTVOIXFBH-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmaco... Bioorg Med Chem Lett. 2004 Jan 19;14(2):351-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.